AR027485A1 - Sistema terapeutico percutaneo con nicotina, metodo para disimular el mal olor del mismo y uso de un aceite esencial - Google Patents
Sistema terapeutico percutaneo con nicotina, metodo para disimular el mal olor del mismo y uso de un aceite esencialInfo
- Publication number
- AR027485A1 AR027485A1 ARP000101319A ARP000101319A AR027485A1 AR 027485 A1 AR027485 A1 AR 027485A1 AR P000101319 A ARP000101319 A AR P000101319A AR P000101319 A ARP000101319 A AR P000101319A AR 027485 A1 AR027485 A1 AR 027485A1
- Authority
- AR
- Argentina
- Prior art keywords
- essential oil
- nicotine
- type
- peppermint
- percutaneous therapeutic
- Prior art date
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title abstract 7
- 229960002715 nicotine Drugs 0.000 title abstract 7
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title abstract 7
- 239000000341 volatile oil Substances 0.000 title abstract 7
- 230000001225 therapeutic effect Effects 0.000 title abstract 6
- 235000016257 Mentha pulegium Nutrition 0.000 abstract 4
- 244000246386 Mentha pulegium Species 0.000 abstract 4
- 235000004357 Mentha x piperita Nutrition 0.000 abstract 4
- 235000001050 hortel pimenta Nutrition 0.000 abstract 4
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describe un sistema terapéutico percutáneo con una capa posterior, por lo menos una capa o zona que contiene nicotina, que puede tener tambiénpropiedades adhesivas, así como una capa de proteccion separable, que se caracteriza por un contenido de por lo menos un aceite esencial, obtenido a partir deun tipo de menta, o una monoterpencetona presente en esto aceites esenciales. También se describe un método para recubrir el olor desagradable de estossistemas terapéuticos percutáneos debido al co ntenido de nicotina, en el cual se anade al sistema terapéutico percutáneo que contiene nicotina por lo menos unasustancia que mejora el olor, la cual puede ser un aceite esencial obtenido a partir de un tipo de menta, o una monoterpencetona contenid a en un aceiteesencial obtenido a partir de un tipo de menta. Asimismo se describe el uso de un aceite esencial obtenido a partir de un tipo de menta y/o de unamonoterpencetona, contenida a su vez en un aceite esencial obtenido a partir de un tipo de menta, para recubrir el olor desagradable que presentan estossistemas terapéuticos percutáneos debido a su contenido de nicotina. El objtivo de la presente es, por lo tanto, neutralizar o recubrir en forma agradable elolor a nicotina de los sistemas terapéuticos transdermales que contienen nicotina, a través del agregado de los aditivos descriptos más arriba.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19913732A DE19913732A1 (de) | 1999-03-26 | 1999-03-26 | Nikotin-TTS mit einem Zusatz von Monoterpenketonen |
Publications (1)
Publication Number | Publication Date |
---|---|
AR027485A1 true AR027485A1 (es) | 2003-04-02 |
Family
ID=7902491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000101319A AR027485A1 (es) | 1999-03-26 | 2000-03-24 | Sistema terapeutico percutaneo con nicotina, metodo para disimular el mal olor del mismo y uso de un aceite esencial |
Country Status (23)
Country | Link |
---|---|
US (1) | US7029692B1 (es) |
EP (1) | EP1164996B1 (es) |
JP (1) | JP4750282B2 (es) |
KR (1) | KR100597802B1 (es) |
CN (1) | CN1199623C (es) |
AR (1) | AR027485A1 (es) |
AT (1) | ATE252356T1 (es) |
AU (1) | AU769656B2 (es) |
BR (1) | BR0010515A (es) |
CA (1) | CA2367615C (es) |
CZ (1) | CZ300409B6 (es) |
DE (2) | DE19913732A1 (es) |
DK (1) | DK1164996T3 (es) |
ES (1) | ES2211523T3 (es) |
HU (1) | HUP0200189A3 (es) |
IL (1) | IL145502A0 (es) |
NZ (1) | NZ514423A (es) |
PT (1) | PT1164996E (es) |
RU (1) | RU2228740C2 (es) |
TR (1) | TR200102605T2 (es) |
TW (1) | TWI227666B (es) |
WO (1) | WO2000057824A1 (es) |
ZA (1) | ZA200107864B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002011768A1 (en) * | 2000-08-03 | 2002-02-14 | Antares Pharma Ipl Ag | Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
US20070225379A1 (en) * | 2001-08-03 | 2007-09-27 | Carrara Dario Norberto R | Transdermal delivery of systemically active central nervous system drugs |
US7198801B2 (en) * | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
US7387788B1 (en) | 2003-10-10 | 2008-06-17 | Antares Pharma Ipl Ag | Pharmaceutical compositions of nicotine and methods of use thereof |
AU2004283431B2 (en) | 2003-10-10 | 2009-09-10 | Antares Pharma Ipl Ag | Transdermal pharmaceutical formulation for minimizing skin residues |
WO2006125642A1 (en) | 2005-05-27 | 2006-11-30 | Antares Pharma Ipl Ag | Methods and apparatus for transdermal or transmucosal application of testosterone |
KR100699582B1 (ko) | 2005-07-11 | 2007-03-23 | 삼성전기주식회사 | 출력 버퍼회로 |
DE102005033543A1 (de) * | 2005-07-14 | 2007-01-18 | Grünenthal GmbH | Ein einen Duftstoff aufweisendes transdermales therapeutisches System |
IL177071A0 (en) * | 2005-08-01 | 2006-12-10 | Nitto Denko Corp | Method of preparing a nicotine transdermal preparation |
EP1774964B1 (en) | 2005-10-13 | 2014-08-06 | Nitto Denko Corporation | Nicotine transdermal preparation and production method thereof |
NZ571460A (en) * | 2006-04-21 | 2010-10-29 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
WO2008067991A2 (en) * | 2006-12-08 | 2008-06-12 | Antares Pharma Ipl Ag | Skin-friendly drug complexes for transdermal administration |
CN101264277B (zh) * | 2008-04-16 | 2012-09-26 | 冯冲 | 一种控烟戒烟复方精油 |
RU2573293C2 (ru) * | 2010-03-26 | 2016-01-20 | Филип Моррис Продактс С.А. | Ингибирование раздражающих ощущений при потреблении некурительных табачных продуктов |
JP5730355B2 (ja) * | 2013-07-24 | 2015-06-10 | 学校法人近畿大学 | Cyp2a13阻害剤 |
JP6888974B2 (ja) * | 2016-01-27 | 2021-06-18 | 学校法人近畿大学 | Cyp2a13阻害活性を有する化合物及びcyp2a13阻害剤 |
US20190083386A1 (en) | 2017-09-15 | 2019-03-21 | Ampersand Biopharmaceuticals, Inc. | Methods and formulations for transdermal administration of buffering agents |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3559655A (en) * | 1969-02-25 | 1971-02-02 | Sutton Res Corp | Oxidized cellulose substitute smoking material and method of making same |
US4039653A (en) * | 1974-01-23 | 1977-08-02 | Defoney, Brenman, Mayes & Baron | Long-acting articles for oral delivery and process |
US4933184A (en) * | 1983-12-22 | 1990-06-12 | American Home Products Corp. (Del) | Menthol enhancement of transdermal drug delivery |
JPH01157921A (ja) * | 1987-12-15 | 1989-06-21 | Tsumura & Co | 二重盲検試験用製剤の製造方法 |
JPH01290608A (ja) * | 1988-05-18 | 1989-11-22 | Sunstar Inc | 殺菌剤組成物 |
ES2062093T3 (es) * | 1988-08-02 | 1994-12-16 | Ciba Geigy Ag | Emplasto de varias capas. |
JP2905210B2 (ja) * | 1989-01-23 | 1999-06-14 | フロイント産業株式会社 | 経皮、経粘膜吸収促進剤および経皮、経粘膜製剤 |
JPH0748190B2 (ja) * | 1990-01-22 | 1995-05-24 | 株式会社東芝 | キャッシュメモリ内蔵マイクロプロセッサ |
JPH0679002A (ja) * | 1993-12-14 | 1994-03-22 | Hisamitsu Pharmaceut Co Inc | 経皮投与用パッチシステム |
JPH06181972A (ja) * | 1992-12-18 | 1994-07-05 | Kanebo Ltd | 煙草臭消臭剤 |
US5520924A (en) * | 1993-07-09 | 1996-05-28 | Mizu Systems Corporation | Methods and articles for administering drug to the oral cavity |
US5362496A (en) * | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
DE4332094C2 (de) * | 1993-09-22 | 1995-09-07 | Lohmann Therapie Syst Lts | Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung |
JPH07133490A (ja) * | 1993-11-10 | 1995-05-23 | Pola Chem Ind Inc | 消臭剤 |
WO1996000072A1 (en) * | 1994-06-23 | 1996-01-04 | The Procter & Gamble Company | Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine |
JPH09110680A (ja) * | 1995-10-19 | 1997-04-28 | Yuutoku Yakuhin Kogyo Kk | 皮膚炎治療貼付剤 |
JPH10130118A (ja) * | 1996-10-25 | 1998-05-19 | Lion Corp | 外用剤組成物 |
JPH10306030A (ja) * | 1997-05-07 | 1998-11-17 | Taisho Pharmaceut Co Ltd | 外用剤組成物 |
-
1999
- 1999-03-26 DE DE19913732A patent/DE19913732A1/de not_active Withdrawn
-
2000
- 2000-03-21 NZ NZ514423A patent/NZ514423A/en not_active IP Right Cessation
- 2000-03-21 AT AT00916981T patent/ATE252356T1/de active
- 2000-03-21 WO PCT/EP2000/002457 patent/WO2000057824A1/de active IP Right Grant
- 2000-03-21 KR KR1020017012169A patent/KR100597802B1/ko active IP Right Grant
- 2000-03-21 CN CNB008055254A patent/CN1199623C/zh not_active Expired - Lifetime
- 2000-03-21 BR BR0010515-5A patent/BR0010515A/pt not_active IP Right Cessation
- 2000-03-21 DK DK00916981T patent/DK1164996T3/da active
- 2000-03-21 CZ CZ20013457A patent/CZ300409B6/cs not_active IP Right Cessation
- 2000-03-21 AU AU38134/00A patent/AU769656B2/en not_active Expired
- 2000-03-21 US US09/937,534 patent/US7029692B1/en not_active Expired - Lifetime
- 2000-03-21 EP EP00916981A patent/EP1164996B1/de not_active Expired - Lifetime
- 2000-03-21 IL IL14550200A patent/IL145502A0/xx not_active IP Right Cessation
- 2000-03-21 ES ES00916981T patent/ES2211523T3/es not_active Expired - Lifetime
- 2000-03-21 HU HU0200189A patent/HUP0200189A3/hu unknown
- 2000-03-21 JP JP2000607578A patent/JP4750282B2/ja not_active Expired - Lifetime
- 2000-03-21 RU RU2001125674/15A patent/RU2228740C2/ru active
- 2000-03-21 DE DE50004156T patent/DE50004156D1/de not_active Expired - Lifetime
- 2000-03-21 PT PT00916981T patent/PT1164996E/pt unknown
- 2000-03-21 TR TR2001/02605T patent/TR200102605T2/xx unknown
- 2000-03-21 CA CA002367615A patent/CA2367615C/en not_active Expired - Lifetime
- 2000-03-24 AR ARP000101319A patent/AR027485A1/es active IP Right Grant
- 2000-03-24 TW TW089105397A patent/TWI227666B/zh not_active IP Right Cessation
-
2001
- 2001-09-25 ZA ZA200107864A patent/ZA200107864B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE50004156D1 (de) | 2003-11-27 |
AU3813400A (en) | 2000-10-16 |
US7029692B1 (en) | 2006-04-18 |
JP4750282B2 (ja) | 2011-08-17 |
EP1164996A1 (de) | 2002-01-02 |
ATE252356T1 (de) | 2003-11-15 |
PT1164996E (pt) | 2004-03-31 |
HUP0200189A3 (en) | 2011-02-28 |
TR200102605T2 (tr) | 2002-01-21 |
AU769656B2 (en) | 2004-01-29 |
CN1199623C (zh) | 2005-05-04 |
DK1164996T3 (da) | 2004-02-16 |
HUP0200189A2 (hu) | 2002-05-29 |
IL145502A0 (en) | 2002-06-30 |
KR100597802B1 (ko) | 2006-07-10 |
CA2367615A1 (en) | 2000-10-05 |
CA2367615C (en) | 2009-10-13 |
RU2228740C2 (ru) | 2004-05-20 |
BR0010515A (pt) | 2003-07-22 |
WO2000057824A1 (de) | 2000-10-05 |
CZ20013457A3 (cs) | 2002-03-13 |
EP1164996B1 (de) | 2003-10-22 |
DE19913732A1 (de) | 2000-09-28 |
TWI227666B (en) | 2005-02-11 |
ES2211523T3 (es) | 2004-07-16 |
NZ514423A (en) | 2003-08-29 |
KR20010112366A (ko) | 2001-12-20 |
CN1345213A (zh) | 2002-04-17 |
ZA200107864B (en) | 2002-11-27 |
CZ300409B6 (cs) | 2009-05-13 |
PL351313A1 (en) | 2003-04-07 |
JP2002540125A (ja) | 2002-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR027485A1 (es) | Sistema terapeutico percutaneo con nicotina, metodo para disimular el mal olor del mismo y uso de un aceite esencial | |
MA32232B1 (fr) | Nouveaux compoés hétérocycliques et leurs utilisations | |
EP4285906A3 (en) | Amine-substituted heterocyclic compounds as ehmt2 inhibitors and methods of use thereof | |
AR059210A1 (es) | Composiciones antitranspirantes | |
BRPI0720270B8 (pt) | compostos 4-fenil-6-(2,2,2-triflúor-1-fenil etoxi) pirimidina, composição e forma de dosagem sólida | |
CO5700767A2 (es) | Procedimiento de tratamiento de rechazo de transplantes | |
UY27943A1 (es) | Composiciones y mctodos para tratar el crncer usando inmunoconjugados de anticuerpo para cd44 citotnxicos y agentes quimioterapcuticos | |
ATE403700T1 (de) | Desodorierungsmittel und harzzusammensetzung | |
BR0306988A (pt) | Piridazinonas substituìdas como inibidores de p38 | |
BRPI0516105A (pt) | composições de fator de crescimento derivado de plaqueta e métodos de uso destas | |
BRPI0516463A (pt) | cánula escalonada e conjunto de cánula | |
SG171682A1 (en) | Iap bir domain binding compounds | |
BRPI0511036A (pt) | formulações de solução farmacêuticas contendo 17-aag | |
BR112015029615A8 (pt) | uso cosmético, processo cosmético, composição e uso de um material silicioso | |
WO2006097793A3 (en) | Compositions capable of facilitating penetration across a biological barrier | |
BR0316305A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, métodos para tratar a dor em um animal, para estimular a função do receptor opióide em uma célula, para preparar uma composição, e para tratar diarréia em um animal, composição, e kit | |
MY162512A (en) | Deodorant composition | |
TW200833364A (en) | Emulsion composition for hair product | |
DE60135647D1 (de) | Zusammensetzungen zur normalisierung des zirkadianen rythmus | |
DOP2006000175A (es) | Heterociclos de 1,4-dihidropiridina condensados, procesos para preparar los mismos, uso y composiciones que los contienen | |
BRPI0607703A2 (pt) | compostos de isoquinolina e métodos de uso dos mesmos | |
AR052322A1 (es) | Compuestos de n-benzoil-estaurosporina, procesos para su preparacion y composicion farmaceutica | |
AR059320A1 (es) | Composicion antitumorial que comprende un inhibidor de quinasas dependientes de ciclinas y un anticuerpo que inhibe un factor de crecimiento y/o un compuesto antimitotico | |
DE60219782D1 (de) | Pharmazeutische und/oder kosmetische zusammensetzung zur behandlung von lokaler adipositas und zellulitis | |
ATE417633T1 (de) | Zusammensetzungen und verfahren zur bekämpfung von toilettengeruch |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |